Does Zinc Colds Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Zinc Colds Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - This observation led the father of the child, George Eby, to conduct a randomized controlled trial (RCT), which found that zinc gluconate lozenges significantly shortened colds (), and increased the recovery rate from the common cold with a rate ratio (RR) of 3.5 (95% CI: 1.8–6.7) compared to placebo (). [Hemilä Harri (2024); evidence level 1] - In three zinc acetate lozenge trials, the rate of recovery from the common cold increased with a RR of 3.1 (95% CI: 2.1–4.7) (). [Hemilä Harri (2024); evidence level 1] - Thus, there is strong evidence that appropriately composed zinc lozenges, especially zinc acetate lozenges, can help to treat colds. [Hemilä Harri (2024); evidence level 1] - 1 2 1 3 Interest in zinc lozenges (tablets to be dissolved slowly in the mouth) for common cold treatment started from the serendipitous observation that the cold symptoms of a 3-year-old girl with leukemia disappeared within a few hours when she allowed a zinc tablet to slowly dissolve in her mouth instead of swallowing it whole (,). [Hemilä Harri (2024); evidence level 1] - Background Effects of treatments on continuous outcomes are commonly estimated using the mean difference (in units of measurement) or the ratio of means (percentages), each providing a single average effect across the study population. [Hemilä H (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.